Mechanisms of CD8+ T cell peripheral tolerance to our own antigens

Frontiers in Bioscience

Volumn 10, Issue 2, 2005, Pages 1628-1634

  Paroli, Marino ^a,b   Barnaba, Vincenzo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b POLICLINICO UMBERTO I   (Italy)

Author keywords

CD8+ T cells; Dendritic Cells; Peripheral Tolerance; Regulatory T cells; Review; Self Antigens

Indexed keywords

ANTIGEN; CD40 LIGAND; CD8 ANTIGEN;

ANTIGEN FUNCTION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; AUTOIMMUNITY; CELLULAR IMMUNITY; CROSS PRESENTATION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; ENDOCYTOSIS; HUMAN; IMMUNE STATUS; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; LYMPHOID ORGAN; PROGENY; REVIEW; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 17244378383     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1646     Document Type: Review

References (79)

1. Barnaba V.: Viruses, hidden self-epitopes and autoimmunity. Immunol Rev 152, 47-66 (1996)
2. Bevan M. J.: Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J Exp Med 143, 1283-1288 (1976)
3. Barnaba V., A. Franco, A. Alberti, R. Benvenuto & F. Balsano: Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes. Nature 345, 258-260 (1990)
4. den Haan J. M. & M. J. Bevan: Antigen presentation to CD8+ T cells: cross-priming in infectious diseases. Curr Opin Immunol 13, 437-441 (2001)
5. Jung S., D. Unutmaz, P. Wong, G. Sano, K. De los Santos, T. Sparwasser, S. Wu, S. Vuthoori, K. Ko, F. Zavala, E. G. Pamer, D. R. Littman & R. A. Lang: In vivo depletion of CD11c(+) dendritic cells abrogates priming of CD8(+) T cells by exogenous cell-associated antigens. Immunity 17, 211-220 (2002)
6. Steinman R. M. & M. C. Nussenzweig: Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci U S A 99, 351-358 (2002)
7. Steinman R. M.: The control of immunity and tolerance by dendritic cell. Pathol Biol (Paris) 51, 59-60 (2003)
8. Steinman R. M., D. Hawiger & M. C. Nussenzweig: Tolerogenic dendritic cells. Annu Rev Immunol 21, 685-711 (2003)
9. Guermonprez P., J. Valladeau, L. Zitvogel, C. Thery & S. Amigorena: Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol 20, 621-667 (2002)
10. Lanzavecchia A.: Mechanisms of antigen uptake for presentation. Curr Opin Immunol 8, 348-354 (1996)
11. Lanzavecchia A. & F. Sallusto: The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics. Curr Opin Immunol 13, 291-298 (2001)
12. Lanzavecchia A. & F. Sallusto: Regulation of T cell immunity by dendritic cells. Cell 106, 263-266 (2001)
13. Finkelman F. D., A. Lees, R. Birnbaum, W. C. Gause & S. C. Morris: Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion. J Immunol 157, 1406-1414 (1996)
14. Heath W. R. & F. R. Carbone: Cross-presentation, dendritic cells, tolerance and immunity. Annu Rev Immunol 19, 47-64 (2001)
15. Mahnke K., J. Knop & A. H. Enk: Induction of tolerogenic DCs: 'you are what you eat'. Trends Immunol 24, 646-651 (2003)
16. Propato A., G. Cutrona, V. Francavilla, M. Ulivi, E. Schiaffella, O. Landt, R. Dunbar, V. Cerundolo, M. Ferrarini & V. Barnaba: Apoptotic cells overexpress vinculin and induce vinculin-specific cytotoxic T-cell cross-priming. Nat Med 7, 807-813 (2001)
17. Bennett S. R., F. R. Carbone, F. Karamalis, R. A. Flavell, J. F. Miller & W. R. Heath: Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393, 478-480 (1998)
18. Janssen E. M., E. E. Lemmens, T. Wolfe, U. Christen, M. G. von Herrath & S. P. Schoenberger: CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature421, 852-856 (2003)
19. Ridge J. P., F. Di Rosa & P. Matzinger: A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 393, 474-478 (1998)
20. Schoenberger S. P., R. E. Toes, E. I. van der Voort, R. Offringa & C. J. Melief: T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393, 480-483 (1998)
21. Norbury C. C., S. Basta, K. B. Donohue, D. C. Tscharke, M. F. Princiotta, P. Berglund, J. Gibbs, J. R. Bennink & J. W. Yewdell: CD8+ T cell cross-priming via transfer of proteasome substrates. Science 304, 1318-1321 (2004)
22. Wolkers M. C., N. Brouwenstijn, A. H. Bakker, M. Toebes & T. N. Schumacher: Antigen bias in T cell cross-priming. Science 304, 1314-1317 (2004)
23. Hugues S., L. Fetler, L. Bonifaz, J. Helft, F. Amblard & S. Amigorena: Distinct T cell dynamics in lymph nodes during the induction of tolerance and immunity. Nat Immunol 31, 31 (2004)
24. Ohlen C., M. Kalos, L. E. Cheng, A. C. Shur, D. J. Hong, B. D. Carson, N. C. Kokot, C. G. Lerner, B. D. Sather, E. S. Huseby & P. D. Greenberg: CD8(+) T cell tolerance to a tumor-associated antigen is maintained at the level of expansion rather than effector function. J Exp Med 195, 1407-1418 (2002)
25. Albert M. L., M. Jegathesan & R. B. Darnell: Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells. Nat Immunol 2, 1010-1017 (2001)
26. Liu K., T. Iyoda, M. Saternus, Y. Kimura, K. Inaba & R. M. Steinman: Immune tolerance after delivery of dying cells to dendritic cells in situ. J Exp Med 196, 1091-1097 (2002)
27. Kurts C., H. Kosaka, F. R. Carbone, J. F. Miller & W. R. Heath: Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J Exp Med 186, 239-245 (1997)
28. Gershon R. K. & K. Kondo: Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology 18, 723-737 (1970)
29. Janeway C. A., Jr.: Do suppressor T cells exist? A reply. Scand J Immunol 27, 621-623 (1988)
30. Baecher-Allan C. & D. A. Hafler: Suppressor T cells in human diseases. J Exp Med200, 273-276. (2004)
31. Dieckmann D., H. Plottner, S. Berchtold, T. Berger & G. Schuler: Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J Exp Med 193, 1303-1310 (2001)
32. Nishimura E., T. Sakihama, R. Setoguchi, K. Tanaka & S. Sakaguchi: Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells. Int Immunol 16, 1189-1201 (2004)
33. Jonuleit H., E. Schmitt, M. Stassen, A. Tuettenberg, J. Knop & A. H. Enk: Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med 193, 1285-1294 (2001)
34. Sakaguchi S.: Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22, 531-562 (2004)
35. Asseman C., S. Mauze, M. W. Leach, R. L. Coffman & F. Powrie: An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 190, 995-1004 (1999)
36. D'Orazio T. J. & J. Y. Niederkorn: A novel role for TGF-beta and IL-10 in the induction of immune privilege. J Immunol 160, 2089-2098 (1998)
37. Gorelik L. & R. A. Flavell: Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12, 171-181 (2000)
38. Jonuleit H., E. Schmitt, G. Schuler, J. Knop & A. H. Enk: Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 192, 1213-1222 (2000)
39. Maloy K. J., L. Salaun, R. Cahill, G. Dougan, N. J. Saunders & F. Powrie: CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 197, 111-119 (2003)
40. Nakamura K., A. Kitani & W. Strober: Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 194, 629-644 (2001)
41. Grossman W. J., J. W. Verbsky, W. Barchet, M. Colonna, J. P. Atkinson & T. J. Ley: Human T regulatory bcells can use the perform pathway to cause autologous target cell death. Immunity 21, 589-601 (2004)
42. Cederbom L., H. Hall & F. Ivars: CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur J Immunol 30, 1538-1543 (2000)
43. Fontenot J. D., M. A. Gavin & A. Y. Rudensky: Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4, 330-336 (2003)
44. Hori S., T. Nomura & S. Sakaguchi: Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061 (2003)
45. Khattri R., T. Cox, S. A. Yasayko & F. Ramsdell: An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 4, 337-342 (2003)
46. Bennett C. L., J. Christie, F. Ramsdell, M. E. Brunkow, P. J. Ferguson, L. Whitesell, T. E. Kelly, F. T. Saulsbury, P. F. Chance & H. D. Ochs: The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27, 20-21 (2001)
47. Brunkow M. E., E. W. Jeffery, K. A. Hjerrild, B. Paeper, L. B. Clark, S. A. Yasayko, J. E. Wilkinson, D. Galas, S. F. Ziegler & F. Ramsdell: Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 27, 68-73 (2001)
48. Chen W., W. Jin, N. Hardegen, K. J. Lei, L. Li, N. Marinos, G. McGrady & S. M. Wahl: Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198, 1875-1886 (2003)
49. Fehervari Z. & S. Sakaguchi: Control of Foxp3+CD25+CD4+ regulatory cell activation and function by dendritic cells. Int Immunol 1, 1 (2004)
50. Itoh M., T. Takahashi, N. Sakaguchi, Y. Kuniyasu, J. Shimizu, F. Otsuka & S. Sakaguchi: Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol 162, 5317-5326 (1999)
51. Fehervari Z. & S. Sakaguchi: Development and function of CD25+CD4+ regulatory T cells. Curr Opin Immunol 16, 203-208 (2004)
52. de la Rosa M., S. Rutz, H. Dorninger & A. Scheffold: Interleukin-2 is essential for CD4+CD25+ regulatory T cell function. Eur J Immunol 34, 2480-2488 (2004)
53. Piccirillo C. A. & E. M. Shevach: Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells. J Immunol 167, 1137-1140 (2001)
54. Thornton A. M., E. E. Donovan, C. A. Piccirillo & E. M. Shevach: Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function. J Immunol 172, 6519-6523 (2004)
55. Thornton A. M., C. A. Piccirillo & E. M. Shevach: Activation requirements for the induction of CD4+CD25+ T cell suppressor function. Eur J Immunol 34, 366-376 (2004)
56. Paust S., L. Lu, N. McCarty & H. Cantor: Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc Natl Acad Sci U S A 101, 10398-10403 (2004)
57. O'Sullivan B. & R. Thomas: CD40 and dendritic cell function. Crit Rev Immunol 23, 83-107 (2003)
58. Bluestone J. A. & A. K. Abbas: Natural versus adaptive regulatory T cells. Nat Rev Immunol 3, 253-257 (2003)
59. Hsieh C. S., Y. Liang, A. J. Tyznik, S. G. Self, D. Liggitt & A. Y. Rudensky: Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity 21, 267-277 (2004)
60. Roncarolo M. G. & M. K. Levings: The role of different subsets of T regulatory cells in controlling autoimmunity. Curr Opin Immunol 12, 676-683 (2000)
61. Roncarolo M. G., R. Bacchetta, C. Bordignon, S. Narula & M. K. Levings: Type 1 T regulatory cells. Immunol Rev 182, 68-79 (2001)
62. Weiner H. L.: Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol Rev 182, 207-214 (2001)
63. Shevach E. M.: CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2, 389-400 (2002)
64. Cosmi L., F. Liotta, E. Lazzeri, M. Francalanci, R. Angeli, B. Mazzinghi, V. Santarlasci, R. Manetti, V. Vanini, P. Romagnani, E. Maggi, S. Romagnani & F. Annunziato: Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes. Blood 102, 4107-4114 (2003)
65. Douillard P., C. Vignes, R. Josien, E. Chiffoleau, J. M. Heslan, V. Proust, J. P. Soulillou & M. C. Cuturi: Reassessment of the role of CD8+ T cells in the induction of allograft tolerance by donor-specific blood transfusion. Eur J Immunol 29, 1919-1924. (1999)
66. Jiang H., H. Kashleva, L. X. Xu, J. Forman, L. Flaherty, B. Pernis, N. S. Braunstein & L. Chess: T cell vaccination induces T cell receptor Vbeta-specific Qa-1-restricted regulatory CD8(+) T cells. Proc Natl Acad Sci U S A 95, 4533-4537 (1998)
67. Jiang H. & L. Chess: The specific regulation of immune responses by CD8+ T cells restricted by the MHC class Ib molecule, Qa-1. Annu Rev Immunol 18, 185-216 (2000)
68. Jiang H., S. Curran, E. Ruiz-Vazquez, B. Liang, R. Winchester & L. Chess: Regulatory CD8+ T cells fine-tune the myelin basic protein-reactive T cell receptor V beta repertoire during experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 100, 8378-8383 (2003)
69. Sarantopoulos S., L. Lu & H. Cantor: Qa-1 restriction of CD8(+) suppressor T cells. J Clin Invest 114, 1218-1221. (2004)
70. Accapezzato D., V. Francavilla, M. Paroli, M. Casciaro, L. V. Chircu, A. Cividini, S. Abrignani, M. U. Mondelli & V. Barnaba: Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection. J Clin Invest 113, 963-972 (2004)
71. Xystrakis E., A. S. Dejean, I. Bernard, P. Druet, R. Liblau, D. Gonzalez-Dunia & A. Saoudi: Identification of a novel natural regulatory CD8 T-cell subset and analysis of its mechanism of regulation. Blood 104, 3294-3301 (2004)
72. Kapasi K., S. E. Albert, S. Yie, N. Zavazava & C. L. Librach: HLA-G has a concentration-dependent effect on the generation of an allo-CTL response. Immunology 101, 191-200 (2000)
73. Le Bouteiller P., F. Legrand-Abravanel & C. Solier: Soluble HLA-G1 at the materno-foetal interface - a review. Placenta 24, S10-15. (2003)
74. Cao D., V. Malmstrom, C. Baecher-Allan, D. Hafler, L. Klareskog & C. Trollmo: Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol 33, 215-223 (2003)
75. Curotto de Lafaille M. A. & J. J. Lafaille: CD4(+) regulatory T cells in autoimmunity and allergy. Curr Opin Immunol 14, 771-778 (2002)
76. Ehrenstein M. R., J. G. Evans, A. Singh, S. Moore, G. Warnes, D. A. Isenberg & C. Mauri: Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med 200, 277-285. (2004)
77. Hackstein H. & A. W. Thomson: Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat Rev Immunol 4, 24-34 (2004)
78. Karim M., C. I. Kingsley, A. R. Bushell, B. S. Sawitzki & K. J. Wood: Alloantigen-induced CD25+CD4+ regulatory T cells can develop in vivo from CD25-CD4+ precursors in a thymus-independent process. J Immunol 172, 923-928 (2004)
79. Karlsson M. R., J. Rugtveit & P. Brandtzaeg: Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow's milk allergy. J Exp Med 199, 1679-1688 (2004)